SCHEMBL9404435

SCHEMBL9404435

CN(C)Cc1cc(C2=C(Cl)CCN(OC(=O)C(=O)ON3CCC(Cl)=C(c4cc(CN(C)C)on4)C3)C2)no1

nearest known ligand 0.35

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 2/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNA4 P43681 1/20 0.35
POLB P06746 1/20 0.32
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9404276 0.86 PRMT5 (0.34)
SCHEMBL9404358 0.84 PPARA (0.37)
SCHEMBL9404487 0.82 P2RX7 (0.36) POLB
SCHEMBL9404357 0.77 USP30 (0.41) USP30CHRNB2CHRNA4POLBLMNA
Oxalic Acid SCHEMBL9404430 0.72 CHRNB2 (0.43) USP30CHRNB2CHRNA4POLBLMNA
Oxalic Acid SCHEMBL9404275 0.68 CHRM2 (0.42) LMNA
SCHEMBL9404481 0.63 CHRM1 (0.41)
SCHEMBL9404483 0.61 MAPT (0.34) CHRNB2CHRNA4POLB
SCHEMBL9232450 0.60 ALDH1A1 (0.40) POLBLMNA
SCHEMBL20031303 0.57 NOTUM (0.62) POLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5356912-A 3-(5-isoxazolyl)-1-methyl-1,2,3,6-tetrahydropyridine useful for treating Alzheimer's disease NOVO NORDISK A/S (DK) 1994-10-18 US disclosed
US-5262427-A Cognition activators for Alzheimer*s disease NOVO NORDISK A/S (DK) 1993-11-16 US disclosed
EP-0316718-A2 Azacyclic compounds and their preparation and use NOVO NORDISK A/S (DK) 1989-05-24 EP disclosed